IPP Bureau
Sher-I-Kashmir Institute of Medical Sciences and Medtronic partner to open Surgical Skills Lab
By IPP Bureau - September 01, 2021
The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise
US FDA clears InnoCare’s clinical trial of pan-TRK Inhibitor ICP-723
By IPP Bureau - August 31, 2021
The clinical trial will evaluate the safety, tolerability and pharmacokinetic properties of ICP-723 in patients with solid tumours, and evaluate the anti-tumour efficacy of ICP-723 on NTRK fusion-positive cancers
US FDA grants Lantern Pharma additional Orphan Drug tag for LP-184
By IPP Bureau - August 31, 2021
The drug is also intended for the treatment of glioblastoma multiforme
Sun Pharma to commercialise Winlevi in the US and Canada
By IPP Bureau - August 31, 2021
Acne affects up to 50 million Americans annually. The last FDA approval of an acne drug with a new MOA occurred nearly 40 years ago
Sanofi’s Dupixent pivotal trial meets all primary and secondary endpoints for treatment of atopic dermatitis
By IPP Bureau - August 31, 2021
Results reinforce the well-established safety profile of Dupixent - the first-ever biologic medicine for atopic dermatitis currently approved for patients as young 6 years old
Dr. Reddy's announce launch two drugs in the US market
By IPP Bureau - August 31, 2021
Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP are available in one strength of 5 mg/2.5 mg capsules in bottle count sizes of 100
Vivo Bio Tech enters long-term contract with Bio E
By IPP Bureau - August 30, 2021
The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years
Union Minister Sonowal announces major plans for promoting Ayush in NE
By IPP Bureau - August 30, 2021
A sum of Rs 70 crores and Rs 10 crores for a new Ayurvedic college in Assam and upgradation of the ayurvedic college in Guwahati respectively
Granules India receives approval from Health Canada for arthritis drug
By IPP Bureau - August 30, 2021
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
Acute therapies drive overall pharma growth in July: Ind-Ra
By IPP Bureau - August 30, 2021
The segment delivered strong sales growth of 20% YoY
Visby Medical receives FDA approval and CLIA waiver for PCR sexual health test
By IPP Bureau - August 30, 2021
The Visby Medical sexual health click test is the first instrument-free PCR test for the detection of chlamydia, gonorrhoea and trichomonas, with results available within 30 minutes, during the patient visit
Union Minister Mansukh Mandaviya inaugurates Bharat Biotech’s Ankleshwar facility
By IPP Bureau - August 29, 2021
The facility has the capacity to produce one crore doses per day
DCGI approves Enzene biosimilar Denosumab for Osteoporosis
By IPP Bureau - August 28, 2021
This is Enzene Biosciences third biosimilar to be approved
Indian National Institute validates Livinguard’s face mask
By IPP Bureau - August 28, 2021
Textiles treated with the technology have also been proven to deactivate viruses, including SARS-CoV-2 (the virus that causes COVID-19).
European Commission grants market authorisation for BioMarin’s Voxzogo
By IPP Bureau - August 28, 2021
It is estimated that over 11,000 children across Europe, Middle East, and Africa are affected by achondroplasia and could be eligible for treatment with Voxzogo
